[1] Whatmore AM, Foster JT. Emerging diversity and ongoing expansion of the genus Brucella. Infect Genet Evol, 2021; 92, 104865. doi:  10.1016/j.meegid.2021.104865
[2] Iranikhah M, Nazari R, Fasihi-Ramandi M, et al. Immunogenicity of Brucella trivalent immunogen-containing polyethyleneimine nanostructure targeted with LPS in a mouse model. Curr Microbiol, 2024; 81, 383. doi:  10.1007/s00284-024-03824-4
[3] Attia El Hili H, Maatouk K. Zoonotic potential of brucellosis in marine mammals. Med Trop Sante Int, 2024; 4, mtsi. v4i1.2024. 489.
[4] Liu BF, Liu GT, Ma XP, et al. Epidemiology, clinical manifestations, and laboratory findings of 1, 590 human brucellosis cases in Ningxia, China. Front Microbiol, 2023; 14, 1259479. doi:  10.3389/fmicb.2023.1259479
[5] Li NN, Yu F, Peng FY, et al. Probable sexual transmission of brucellosis. IDCases, 2020; 21, e00871. doi:  10.1016/j.idcr.2020.e00871
[6] La THA, McMillan IA, Dahal P, et al. Tracking sero-molecular trends of swine brucellosis in Hawai'i and the central Pacific. Front Public Health, 2024; 12, 1440933. doi:  10.3389/fpubh.2024.1440933
[7] Anadure RK, Goel J, Sahu S, et al. Recurrent encephalopathy with transverse myelitis: an uncommon presentation of neurobrucellosis. J Neurosci Rural Pract, 2019; 10, 703−6. doi:  10.1055/s-0039-1700600
[8] Shang DQ, Xiao DL, Yin JM. Epidemiology and control of brucellosis in China. Vet Microbiol, 2002; 90, 165−82. doi:  10.1016/S0378-1135(02)00252-3
[9] Lai SJ, Zhou H, Xiong WY, et al. Changing epidemiology of human brucellosis, China, 1955-2014. Emerg Infect Dis, 2017; 23, 184−94. doi:  10.3201/eid2302.151710
[10] Yang HM, Chen QL, Li Y, et al. Vital surveillances: epidemic characteristics, high-risk areas and space-time clusters of human brucellosis — China, 2020–2021. China CDC Wkly, 2023; 5, 17−22. doi:  10.46234/ccdcw2023.004
[11] Chen H, Lin MX, Wang LP, et al. Driving role of climatic and socioenvironmental factors on human brucellosis in China: machine-learning-based predictive analyses. Infect Dis Poverty, 2023; 12, 36. doi:  10.1186/s40249-023-01087-y
[12] Zhang WY, Guo WD, Sun SH, et al. Human brucellosis, Inner Mongolia, China. Emerg Infect Dis, 2010; 16, 2001−3. doi:  10.3201/eid1612.091081
[13] Cao N, Guo SY, Yan T, et al. Epidemiological survey of human brucellosis in Inner Mongolia, China, 2010-2014: a high risk groups-based survey. J Infect Public Health, 2018; 11, 24−9. doi:  10.1016/j.jiph.2017.02.013
[14] Gillis D, Edwards BPM. The utility of joinpoint regression for estimating population parameters given changes in population structure. Heliyon, 2019; 5, e02515. doi:  10.1016/j.heliyon.2019.e02515
[15] Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000; 19, 335−51. doi:  10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
[16] Zhang N, Fang XY, Zhou WZ, et al. Epidemiological characteristics and temporal-spatial clustering analysis on human brucellosis in Jiangsu Province, 2006-2021. Sci Rep, 2023; 13, 20024. doi:  10.1038/s41598-023-46690-z
[17] Wang DL, Li Y, Li TF, et al. Exploration of new methods for the prevention and control of brucellosis in China. People’s Medical Publishing House. 2018. (In Chinese)
[18] Liu MQ, Ge RL, Bi YW. Epidemic analysis on human brucellosis in Xilin Gol League. Chin J Ctrl Endem Dis, 2013; 28, 364−5. (In Chinese)
[19] Zhu LQ, Feng Y, Zhang G, et al. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections. Vaccine, 2016; 34, 395−400. doi:  10.1016/j.vaccine.2015.09.116
[20] Chen WJ, Cui BY, Zhang QH, et al. Analysis of epidemic characteristics on brucellosis in Inner Mongolia. Chin J Ctrl Endem Dis, 2008; 23, 56−8. (In Chinese)
[21] Zhao YL, Wang DL, Gang SL. Analysis of monitor results of national major monitoring point for brucellosis in 2002. Chin J Ctrl Endem Dis, 2003; 18, 297−8. (In Chinese)
[22] Bao H, Bai BX, Mu L. Risk assessment of tracing and investigation of brucellosis in Xilingol League. Vet Orientat, 2018; 49-50. (In Chinese)
[23] Liu SJ, Soontornchai S, Bovornkitti S, et al. Epidemiological characteristics and spatio-temporal clusters of human brucellosis in Inner Mongolia, 2010-2021. BMC Infect Dis, 2024; 24, 1321. doi:  10.1186/s12879-024-10165-x
[24] Yang Y, Wu G. A brief analysis on prevention and control strategies for brucellosis. World's Latest Medical Information Digest (Electronic Version). 2015.
[25] Liu ZG, Liu DY, Wang M, et al. Human brucellosis epidemiology in the pastoral area of Hulun Buir city, Inner Mongolia autonomous region, China, between 2003 and 2018. Transbound Emerg Dis, 2022; 69, 1155−65. doi:  10.1111/tbed.14075
[26] Yuan HT, Wang CL, Liu LN, et al. Epidemiologically characteristics of human brucellosis and antimicrobial susceptibility pattern of Brucella melitensis in Hinggan League of the Inner Mongolia Autonomous Region, China. Infect Dis Poverty, 2020; 9, 79. doi:  10.1186/s40249-020-00697-0
[27] Jia P, Joyner A. Human brucellosis occurrences in Inner Mongolia, China: a spatio-temporal distribution and ecological niche modeling approach. BMC Infect Dis, 2015; 15, 36. doi:  10.1186/s12879-015-0763-9
[28] Liu ZG, Gao LP, Wang M, et al. Long ignored but making a comeback: a worldwide epidemiological evolution of human brucellosis. Emerg Microbes Infect, 2024; 13, 2290839. doi:  10.1080/22221751.2023.2290839
[29] Gao S, Peng RH, Zeng Z, et al. Risk transboundary transmission areas and driving factors of brucellosis along the borders between China and Mongolia. Travel Med Infect Dis, 2023; 56, 102648. doi:  10.1016/j.tmaid.2023.102648